C. Basilico

发表

A receptor-antibody hybrid hampering MET-driven metastatic spread

P. Comoglio, E. Vigna, Chiara Modica, 2021, Journal of experimental & clinical cancer research : CR.

Efficacy of Caspofungin Addition to Trimethoprim-Sulfamethoxazole Treatment for Severe Pneumocystis Pneumonia in Solid Organ Transplant Recipients

P. Grossi, E. Durante-Mangoni, R. Utili, 2007, Transplantation.

Dual anti-idiotypic purification of a novel, native-format biparatopic anti-MET antibody with improved in vitro and in vivo efficacy

B. Lambrecht, Natalie de Jonge, C. Blanchetot, 2016, Scientific Reports.

Tivantinib (ARQ197) Displays Cytotoxic Activity That Is Independent of Its Ability to Bind MET—Response

S. Pennacchietti, P. Michieli, C. Basilico, 2013, Clinical Cancer Research.

Levels of the bcl-2 protein, fibronectin and α5β1 fibronectin receptor in HIV-1-infected patients with Kaposi’s sarcoma

D. Torre, C. Basilico, A. Pugliese, 2000 .

Fatal lactic acidosis associated with tenofovir and abacavir.

P. Grossi, C. Basilico, M. Giola, 2005, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

The PSI Domain of the MET Oncogene Encodes a Functional Disulfide Isomerase Essential for the Maturation of the Receptor Precursor

P. Comoglio, A. Bocedi, C. Milanese, 2022, International journal of molecular sciences.

A High Affinity Hepatocyte Growth Factor-binding Site in the Immunoglobulin-like Region of Met

P. Comoglio, P. Michieli, M. Galluzzo, 2008, Journal of Biological Chemistry.

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.

hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of ‘MET-addicted’ cancers

P. Comoglio, S. Corso, S. Giordano, 2022, Journal of experimental & clinical cancer research : CR.

Four individually druggable MET hotspots mediate HGF-driven tumor progression.

Natalie de Jonge, C. Blanchetot, Els Festjens, 2014, The Journal of clinical investigation.

Different point mutations in the met oncogene elicit distinct biological properties

A. Bardelli, P. Comoglio, S. Giordano, 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth.

A. Bardelli, P. Comoglio, S. Giordano, 1998, Proceedings of the National Academy of Sciences of the United States of America.

MET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma Crosstalk

P. Comoglio, E. Vigna, Chiara Modica, 2018, International journal of molecular sciences.

"Active" cancer immunotherapy by anti-Met antibody gene transfer.

P. Comoglio, M. Mazzone, S. Pennacchietti, 2008, Cancer research.

Evolution of coinfection with human immunodeficiency virus and hepatitis C virus in patients treated with highly active antiretroviral therapy.

M. Moroni, G. Barbarini, D. Torre, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Targeting the MET oncogene by concomitant inhibition of receptor and ligand via an antibody‐“decoy” strategy

P. Comoglio, F. Maione, E. Vigna, 2018, International journal of cancer.

Serum levels of interleukin-18 in patients with uncomplicated Plasmodium falciparum malaria.

A. Matteelli, D. Torre, C. Basilico, 2001, European cytokine network.

Targeting the tumor and its microenvironment by a dual-function decoy Met receptor.

L. Naldini, P. Comoglio, M. Mazzone, 2004, Cancer cell.

HGF/MET Axis Induces Tumor Secretion of Tenascin-C and Promotes Stromal Rewiring in Pancreatic Cancer

Melissa Milan, M. Olivero, E. Vigna, 2021, Cancers.

Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists

A. Bardelli, P. Comoglio, S. Giordano, 1999, Oncogene.

Magic-Factor 1, a Partial Agonist of Met, Induces Muscle Hypertrophy by Protecting Myogenic Progenitors from Apoptosis

Giulio Cossu, Claudia Omes, Vania Broccoli, 2008, PloS one.

Tivantinib (ARQ197) Displays Cytotoxic Activity That Is Independent of Its Ability to Bind MET

A. Bardelli, G. Serini, D. Valdembri, 2013, Clinical Cancer Research.

Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor

P. Comoglio, R. Miggiano, A. Bertolotto, 2021, Frontiers in Immunology.

Cancer Therapy : Preclinical Tivantinib ( ARQ 197 ) Displays Cytotoxic Activity That Is Independent of Its Ability to Bind MET

A. Bardelli, G. Serini, D. Valdembri, 2013 .

Circulating levels of IL-18 in adult and paediatric patients with HIV-1 infection.

F. Castelli, D. Torre, C. Basilico, 2000, AIDS.

Monoclonal Antibodies against the MET/HGF Receptor and Its Ligand: Multitask Tools with Applications from Basic Research to Therapy

M. Prat, Francesca Oltolina, C. Basilico, 2014, Biomedicines.

An HGF–MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activity

R. Chiusaroli, P. Bossù, P. Comoglio, 2002, Nature Biotechnology.

Inhibition of ligand‐independent constitutive activation of the Met oncogenic receptor by the engineered chemically‐modified antibody DN30

P. Comoglio, F. Petronzelli, E. Vigna, 2015, Molecular oncology.

Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody

P. Comoglio, T. Crepaldi, E. Vigna, 2020, Cancers.

An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice.

L. Naldini, M. Risio, P. Comoglio, 2004, The Journal of clinical investigation.

Genetic Ablation of the MET Oncogene Defines a Crucial Role of the HGF/MET Axis in Cell-Autonomous Functions Driving Tumor Dissemination

R. Taulli, F. Bersani, L. Righi, 2023, Cancers.

Improvement of atazanavir-induced hyperbilirubinaemia following TDM-guided atazanavir dose reduction

P. Grossi, D. De Luca, P. Villani, 2008 .